Overview
- Editors:
-
-
Phillip K. Peterson
-
Department of Medicine, University of Minnesota Medical School, Minneapolis, USA
-
Michal Toborek
-
Department of Biochemistry Department of Molecular Biology, University of Miami School of Medicine, Miami, USA
- State of the art reviews by experts in the fields of neuroscience, immunology, microbiology/infectious diseases and pharmacology
- Looks at the convergence of the immune system and the loss of neurons in diseases such as Alzheimer’s, Parkinson’s, Multiple Sclerosis and Huntington’s
- Contains a section on novel approaches to therapy
- Includes supplementary material: sn.pub/extras
Access this book
Other ways to access
Table of contents (27 chapters)
-
Infectious Diseases
-
- Gregory Antell, Michael R. Nonnemacher, Vanessa Pirrone, Brian Wigdahl
Pages 355-385
-
- Uwe Koedel, Matthias Klein, Hans-Walter Pfister
Pages 387-404
-
- Gregory S. Park, Chandy C. John
Pages 405-428
-
Drugs of Abuse and NeuroAIDS
-
Front Matter
Pages 429-429
-
- Honghong Yao, Crystal Bethel-Brown, Shilpa J. Buch
Pages 431-442
-
- Nicole A. Northrop, Bryan K. Yamamoto
Pages 443-462
-
-
- Paige S. Katz, Scott Edwards, Patricia E. Molina
Pages 487-510
-
- Yuri Persidsky, Larisa Gofman, Raghava Potula
Pages 511-526
-
Novel Approaches to Therapy
-
Front Matter
Pages 527-527
-
- JoEllyn M. McMillan, Howard E. Gendelman
Pages 529-546
-
- David J. Graber, William F. Hickey
Pages 547-567
-
- Guy A. Cabral, Melissa Jamerson
Pages 569-587
-
Back Matter
Pages 589-600
About this book
State of the art reviews by experts in the fields of neuroscience, immunology, microbiology/infectious diseases and pharmacology addressing the convergence of the immune system (neuroinflammation) and the loss of neurons (neurodegeneration). Many of the diseases that are discussed in the book are of epidemic proportion, e.g., Alzheimer’s disease, Parkinson’s disease, stroke, viral encephalitides and substance abuse. In addition to discussions of the involvement of neuroinflammation and neurodegeneration in these disorders, scientific reviews are presented on the cells and mediators that participate in defense of and damage to the nervous system. With rare exception, no or inadequate treatment exists for the diseases discussed in this book. An underlying premise of the book is that understanding of their shared pathogenic mechanisms will lead to improved therapies. Given the rapid evolution of the field of Neuroimmune Pharmacology, readers will find this book to be the most timely and authoritative reference on the subject of each of its chapters.
Reviews
“This is an outstanding text and atlas of
neurodegenerative & neuroinflammatory diseases. … This book is for cell
biologists.” (Joseph J. Grenier, Amazon.com, November, 2015)
Editors and Affiliations
-
Department of Medicine, University of Minnesota Medical School, Minneapolis, USA
Phillip K. Peterson
-
Department of Biochemistry Department of Molecular Biology, University of Miami School of Medicine, Miami, USA
Michal Toborek